In contrast, humans or mice that lack PD-1 or cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) exhibit a global autoimmune diathesis that corresponds to the toxicities observed when these structures are targeted in immunotherapy of cancer. The gene discussed is CTLA4; the disease is cancer.